JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
554 * | Wed, 8/1/2012, 2:00 PM - 3:50 PM | CC-Room 23A | |
Drug Combination Studies: From Discovery to Clinical — Topic Contributed Papers | |||
Biopharmaceutical Section | |||
Organizer(s): Gregory Hather, Millennium: The Takeda Oncology Company | |||
Chair(s): Ray Liu, Millennium: The Takeda Oncology Company | |||
2:05 PM | Nonlinear Blending: A General Approach to Synergy Assessment — John J. Peterson, GlaxoSmithKline | ||
2:25 PM | A Phase I/II Clinical Trial Design for Drug Combinations — Xuelin Huang, MD Anderson Cancer Center ; Sangbum Choi, MD Anderson Cancer Center | ||
2:45 PM | Codevelopment of Two Unmarketed Investigational Drugs: FDA Guidance and Experiences — Wen Zeng, FDA ; Greg (Guoxing) Soon, FDA | ||
3:05 PM | Experimental Design for In Vitro Drug Combination Studies — Gregory Hather, Millennium: The Takeda Oncology Company ; Huaihou Chen, Columbia University ; Ray Liu, Millennium: The Takeda Oncology Company | ||
3:25 PM | Applying Parametric and Nonparametric Models to Assess Treatment Effect and Drug Synergy for Combination Therapy — Maiying Kong, University of Louisville ; Jack Lee, Ph.D., MD Anderson Cancer Center | ||
3:45 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.